Bulk Inquiry
Droperidol
- R 4749 - Droleptan - Dridol
Axon 1554
CAS:
548-73-2
Purity:
99%
- Soluble in DMSO
- MF: C22H22FN3O2
- MW: 379.43
Description
Droperidol is a dopamine D2 receptor antagonist with additional alpha-1 adrenergic receptor antagonist activity.
D2 receptor blockade underlies antiemetic and antipsychotic pharmacology, while adrenergic antagonism contributes to hemodynamic and sedative effects. Droperidol is useful as a reference compound in dopamine receptor, antiemetic and CNS safety pharmacology research.
Key Features
- Dopamine D2 receptor antagonist
- Additional alpha-1 adrenergic antagonist activity
- Pharmacology relevant to antiemetic and antipsychotic mechanisms
- Useful reference for CNS and cardiovascular safety studies
Applications
- D2 receptor antagonist assays
- Antiemetic mechanism research
- Neuroleptic pharmacology studies
- Cardiac/QT safety model evaluation
More Information
| Parent CAS No. | 548-73-2 |
|---|---|
| Chemical Name | 1-{1-[4-(4-Fluoro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one |
| SMILES | C1(C=CC(F)=CC=1)C(=O)CCCN1CC=C(N2C(=O)NC3C=CC=CC2=3)CC1 |
| MFCD | MFCD00083290 |
| InChi | InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28) |
| InChiKey | RMEDXOLNCUSCGS-UHFFFAOYSA-N |
| CID | 3168 |
| Short Description | D2/α1 antagonist |
Droperidol
dopamine D2 receptor antagonist
R 4749
Droleptan
Dridol
R4749
R-4749
DRD2
ADRA1
dopamine D2 receptor
D2
Antagonist
dopamine signaling
adrenergic signaling
D2 receptor antagonist assays
Antiemetic mechanism research
Neuroleptic pharmacology studies
Cardiac/QT safety model evaluation
cardiovascular research
GPCR pharmacology
receptor pharmacology
signal transduction
CNS
CAS 548-73-2
Axon Medchem
Axon 1554
Supplier
Vendor
References
- S Purhonen et al. Comparison of tropisetron, droperidol, and saline in the prevention of postoperative nausea and vomiting after gynecologic surgery. Anesth Analg 1997, 84(3), 662-667.
- SJ Wang et al. Droperidol treatment of status migrainosus and refractory migraine. Headache 1997, 37(6), 377-382.
- M Koivuranta et al. The antiemetic efficacy of a combination of ondansetron and droperidol. Anaesthesia 1997, 52(9), 863-868.
Related Products
Other Categories
Get a Quote for
Loading...


